BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27965477)

  • 41. Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis.
    Kendall BJ; Rubenstein JH; Cook MB; Vaughan TL; Anderson LA; Murray LJ; Shaheen NJ; Corley DA; Chandar AK; Li L; Greer KB; Chak A; El-Serag HB; Whiteman DC; Thrift AP
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1412-1419.e3. PubMed ID: 27264393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population.
    Kang MS; Park DI; Oh SY; Yoo TW; Ryu SH; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1656-61. PubMed ID: 17845694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Symptoms of Obstructive Sleep Apnea, Gastroesophageal Reflux and the Risk of Barrett's Esophagus in a Population-Based Case-Control Study.
    Lindam A; Kendall BJ; Thrift AP; Macdonald GA; O'Brien S; Lagergren J; Whiteman DC
    PLoS One; 2015; 10(6):e0129836. PubMed ID: 26090820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus.
    Thrift AP; Kramer JR; Alsarraj A; El-Serag HB
    J Clin Gastroenterol; 2014 Mar; 48(3):218-23. PubMed ID: 23842216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for erosive and non-erosive gastroesophageal reflux disease and Barrett's esophagus in Nothern Sardinia.
    Dore MP; Pes GM; Bassotti G; Farina MA; Marras G; Graham DY
    Scand J Gastroenterol; 2016 Nov; 51(11):1281-7. PubMed ID: 27381266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of bacterial biota in the distal esophagus of Japanese patients with reflux esophagitis and Barrett's esophagus.
    Liu N; Ando T; Ishiguro K; Maeda O; Watanabe O; Funasaka K; Nakamura M; Miyahara R; Ohmiya N; Goto H
    BMC Infect Dis; 2013 Mar; 13():130. PubMed ID: 23496929
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease.
    Almers LM; Graham JE; Havel PJ; Corley DA
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2256-64.e1-3. PubMed ID: 25632808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of Helicobacter pylori on the presence of Barrett's esophagus in Azerbaijan, a high-prevalence area of infection.
    Aghayeva S; Mara KC; Katzka DA
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 31175364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastric surgery does not increase the risk of developing Barrett's esophagus.
    Parrilla P; Liron R; Martinez de Haro LF; Ortiz A; Molina J; De Andrés B
    Am J Gastroenterol; 1997 Jun; 92(6):960-3. PubMed ID: 9177510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Esophageal physiologic profiles within erosive esophagitis in China: Predominantly low-grade esophagitis with low reflux burden.
    Zhang M; Tan N; Li Y; Chen M; Xiao Y
    Neurogastroenterol Motil; 2019 Dec; 31(12):e13702. PubMed ID: 31407469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of body weight on clinical symptoms and endoscopic changes in patients with gastroesophageal reflux disease.
    Krakowska-Stasiak M; Cibor D; Sałapa K; Owczarek D; Mach T
    Przegl Lek; 2016; 73(5):271-5. PubMed ID: 29629738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prevalence of Barrett's esophagus and erosive esophagitis in patients undergoing upper endoscopy for dyspepsia in a VA population.
    Connor MJ; Weston AP; Mayo MS; Sharma P
    Dig Dis Sci; 2004 Jun; 49(6):920-4. PubMed ID: 15309878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statin use is associated with a decreased risk of Barrett's esophagus.
    Nguyen T; Khalaf N; Ramsey D; El-Serag HB
    Gastroenterology; 2014 Aug; 147(2):314-23. PubMed ID: 24798416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic risk factors associated with erosive esophagitis.
    Chua CS; Lin YM; Yu FC; Hsu YH; Chen JH; Yang KC; Shih CH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1375-9. PubMed ID: 19467140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Body mass index and Barrett's oesophagus in women.
    Jacobson BC; Chan AT; Giovannucci EL; Fuchs CS
    Gut; 2009 Nov; 58(11):1460-6. PubMed ID: 19336423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus.
    Eisen GM; Sandler RS; Murray S; Gottfried M
    Am J Gastroenterol; 1997 Jan; 92(1):27-31. PubMed ID: 8995932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The association of body mass index with Barrett's oesophagus.
    Stein DJ; El-Serag HB; Kuczynski J; Kramer JR; Sampliner RE
    Aliment Pharmacol Ther; 2005 Nov; 22(10):1005-10. PubMed ID: 16268976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erosive Esophagitis Portends a Benign Clinical Course in the Majority of Patients.
    Bi D; Katzka DA; Lavey CJ; Geno DM; Ravi K
    Dig Dis Sci; 2020 Nov; 65(11):3244-3252. PubMed ID: 31907769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors for Barrett's esophagus.
    Rubenstein JH
    Curr Opin Gastroenterol; 2014 Jul; 30(4):408-14. PubMed ID: 24859804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.